ORL1 receptor ligands: Structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 8, 2000, Pages 831-834

  Röver, Stephan ^a   Wichmann, Jürgen ^a   Jenck, François ^a   Adam, Geo ^a   Cesura, Andrea M ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; G PROTEIN COUPLED RECEPTOR;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; EMBRYONAL TISSUE; HAMSTER; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

CELL LINE; HUMANS; LIGANDS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES;

ANIMALIA; CRICETINAE;

EID: 0342313481     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00111-6     Document Type: Article

References (19)

1. (a) Reinscheid, R. K.; Nothacker, H.-P.; Bourson, A.; Ardati, A.; Henningsen, R. A.; Bunzow, J. R.; Grandy, D. K.; Langen, H.; Monsma, Jr. F. J.; Civelli, O. Science 1995, 270, 792.
2. (b) Meunier, J.-C.; Mollereau, C.; Toll, L.; Suaudeau, C.; Moisand, C.; Alvinerie, P.; Butour, J.-L.; Guillemot, J.-C.; Ferrara, P. et al. Nature 1995, 377, 532.
3. (a) Mollereau, C.; Parmentier, M.; Mailleux, P.; Butour, J.-L.; Moisand, C.; Chalon, P.; Caput, D.; Vassart, G.; Meunier, J.-C. FEBS Lett. 1994, 341, 33.
4. (b) Bunzow, J. R.; Saez, C.; Mortrud, M.; Bouvier, C.; Williams, J. T.; Low, M.; Grandy, D. K. FEBS Lett. 1994, 347, 284.
5. Butour J.-L., Moisand C., Mazarguil H., Mollereau C., Meunier J.-C. Eur. J. Pharmacol. 321:1997;97.
6. (a) Mogil, J. S.; Grisel, J. E.; Reinscheid, R. K.; Civelli, O.; Belknap, J. K.; Grandy, D. K. Neuroscience 1996, 75, 333.
7. (b) Hao, J.-X.; Xu, I. S.; Wiesenfeld-Hallin, Z.; Xu, X.-J. Pain 1998, 76, 385.
8. (c) Yuan, L.; Han, Z.; Chang, J.-K.; Han, J.-S. Brain Res. 1999, 826, 330.
9. Pomonis J.D., Billington C.J., Levine A.S. Neuro Report. 8:1996;369.
10. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J. Jr., Nothacker H.-P., Civelli O. Proc. Natl. Acad. Sci. USA. 94:1997;14854.
11. (a) Wichmann, J.; Adam, G.; Röver, S.; Cesura, A. M.; Dautzenberg, F. M.; Jenck, F. Bioorg. Med. Chem. Lett. 1999, 9, 2343.
12. (b) Röver, S.; Adam, G.; Cesura, A. M.; Galley, G.; Jenck, F.; Monsma, Jr. F. J.; Wichmann J.; Dautzenberg, F. M. J. Med. Chem. in press.
13. 2), 6.40 (bs, 1H, 3-NH), 6.85 (t, J=7.2, 1H, p-ArH), 6.92 (d, J=8.0 Hz, 2H, o-ArH), 7.26 (t, J=8.0 Hz, 2H, m-ArH).
14. 4, MeOH, rt) in analogy to the method described in ref 7.
15. Cheng Y.-C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
16. Andrews P.R., Craik D.J., Martin J.L. J. Med. Chem. 27:1984;1648.
17. (a) Weinberg, N.; Wolfe, S. J. Am. Chem. Soc. 1994, 116, 9860.
18. (b) Kolossváry, I.; Guida, W. C. J. Am. Chem. Soc. 1993, 115, 2107.
19. t [min]: 2n: 9.9; 2s: 8.44-t-butyl-cyclohexylderivatives (2m and 2r): separation was achieved by conventional LC on silica gel (dichloromethane/methanol 2-5%).